H. Gunawardena, Z. Betteridge, and N. Mchugh, Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression, Rheumatology, vol.4, issue.4, pp.607-619, 2009.
DOI : 10.1038/ncprheum0760

S. Sato, M. Hirakata, M. Kuwana, A. Suwa, S. Inada et al., Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis, Arthritis & Rheumatism, vol.40, issue.5, pp.1571-1577, 2005.
DOI : 10.7326/0003-4819-122-9-199505010-00010

A. Clottu, E. Laffitte, C. Prins, and C. Chizzolini, Response of Mucocutaneous Lesions to Rituximab in a Case of Melanoma Differentiation Antigen 5-Related Dermatomyositis, Dermatology, vol.225, issue.4, pp.376-80, 2012.
DOI : 10.1159/000346573

I. Pau-charles, P. Moreno, K. Ortiz-ibanez, M. Lucero, A. Garcia-herrera et al., Anti-MDA5 positive clinically amyopathic dermatomyositis presenting with severe cardiomyopathy, Journal of the European Academy of Dermatology and Venereology, vol.38, issue.8, pp.1097-1102, 2014.
DOI : 10.3899/jrheum.101220

J. Wang, G. Guo, G. Chen, B. Wu, L. Lu et al., Meta-analysis of the association of dermatomyositis and polymyositis with cancer, British Journal of Dermatology, vol.40, issue.4, pp.838-885, 2013.
DOI : 10.1016/j.lpm.2010.12.013

M. Burnouf, E. Mahé, P. Verpillat, V. Descamps, B. Lebrun-vignes et al., Cutaneous necrosis is predictive of cancer in adult dermatomyositis, Ann Dermatol Venereol, vol.130, pp.313-319, 2003.

M. Labrador-horrillo, M. Martinez, A. Selva-o-'callaghan, E. Trallero-araguas, E. Balada et al., Anti-MDA5 Antibodies in a Large Mediterranean Population of Adults with Dermatomyositis, Journal of Immunology Research, vol.71, issue.8, p.290797, 2014.
DOI : 10.1093/rheumatology/ker408

C. Girard, T. Vincent, and D. Bessis, Dermatomyosite et pneumopathie interstitielle rapidement ??volutive associ??es aux auto-anticorps anti-MDA-5??: une pr??sentation clinique atypique, Annales de Dermatologie et de V??n??r??ologie, vol.140, issue.10, pp.628-662, 2013.
DOI : 10.1016/j.annder.2013.04.083

D. Fiorentino, L. Chung, J. Zwerner, A. Rosen, and L. Casciola-rosen, The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): A??retrospective study, Journal of the American Academy of Dermatology, vol.65, issue.1, pp.25-34, 2011.
DOI : 10.1016/j.jaad.2010.09.016

H. Cao, M. Pan, Y. Kang, Q. Xia, X. Li et al., Clinical manifestations of dermatomyositis and clinically amyopathic dermatomyositis patients with positive expression of anti-melanoma differentiation-associated gene 5 antibody, Arthritis Care & Research, vol.49, issue.10, pp.1602-1612, 2012.
DOI : 10.1093/rheumatology/keq153

Z. Chen, M. Cao, M. Plana, J. Liang, H. Cai et al., Utility of Anti-Melanoma Differentiation-Associated Gene 5 Antibody Measurement in Identifying Patients With Dermatomyositis and a High Risk for Developing Rapidly Progressive Interstitial Lung Disease: A Review of the Literature and a Meta-Analysis, Arthritis Care & Research, vol.64, issue.8, pp.1316-1340, 2013.
DOI : 10.1002/art.34657

M. Miyake, A. Sakai, C. Nishijima, T. Kita, E. Nitta et al., Detection of anti-CADM-140/MDA5 antibodies in a patient with classic dermatomyositis developing rapidly progressive interstitial lung disease, The Journal of Dermatology, vol.41, issue.7, pp.664-669, 2014.
DOI : 10.1111/1346-8138.12524

M. Gerfaud-valentin, K. Ahmad, F. Piegay, N. Fabien, B. Raphanel et al., Pneumopathie infiltrante diffuse associ??e ?? une dermatomyosite amyopathique avec auto-anticorps anti-MDA5, Revue des Maladies Respiratoires, vol.31, issue.9, pp.849-53, 2014.
DOI : 10.1016/j.rmr.2014.02.010

T. Suda, T. Fujisawa, N. Enomoto, Y. Nakamura, N. Inui et al., Interstitial lung diseases associated with amyopathic dermatomyositis, European Respiratory Journal, vol.28, issue.5, pp.1005-1017, 2006.
DOI : 10.1183/09031936.06.00038806

K. Tamai, R. Tachikawa, K. Otsuka, H. Ueda, Y. Hosono et al., Early Pulmonary Involvement of Anti-CADM-140 Autoantibody-positive Rapidly Progressive Interstitial Lung Disease Preceding Typical Cutaneous Symptoms, Internal Medicine, vol.53, issue.21, pp.2515-2524, 2014.
DOI : 10.2169/internalmedicine.53.2769

Y. Sun, Y. Liu, Y. B. Shi, and G. , Interstitial lung disease in clinically amyopathic dermatomyositis (CADM) patients: a retrospective study of 41 Chinese Han patients, Rheumatology International, vol.35, issue.5, pp.1295-302, 2013.
DOI : 10.1093/rheumatology/keq073

H. Mukae, H. Ishimoto, N. Sakamoto, S. Hara, T. Kakugawa et al., Clinical Differences Between Interstitial Lung Disease Associated With Clinically Amyopathic Dermatomyositis and Classic Dermatomyositis, Chest, vol.136, issue.5, pp.1341-1348, 2009.
DOI : 10.1378/chest.08-2740

Y. Shimojima, W. Ishii, T. Kato, K. Hoshi, M. Matsuda et al., Intractable Skin Necrosis and Interstitial Pneumonia in Amyopathic Dermatomyositis, Successfully Treated with Cyclosporin A, Internal Medicine, vol.42, issue.12, pp.1253-1261, 2003.
DOI : 10.2169/internalmedicine.42.1253